DE3347125A1
(de)
*
|
1983-12-22 |
1985-07-11 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
|
GB8430703D0
(en)
*
|
1984-12-05 |
1985-01-16 |
Lrc Products |
Drug release devices
|
FR2618329B1
(fr)
*
|
1987-07-22 |
1997-03-28 |
Dow Corning Sa |
Procede de fabrication d'un anneau capable d'assurer la liberation d'un agent therapeutique, et anneau fabrique par ce procede
|
US6264638B1
(en)
*
|
1989-12-07 |
2001-07-24 |
Ultrafem, Inc. |
Intravaginal drug delivery system and discharge collection device
|
US5295984A
(en)
|
1989-12-07 |
1994-03-22 |
Ultrafem, Inc. |
Vaginal discharge collection device and intravaginal drug delivery system
|
AU1797592A
(en)
*
|
1991-04-12 |
1992-11-17 |
Upjohn Company, The |
Vaginal drug delivery device
|
FI95768C
(fi)
*
|
1993-06-17 |
1996-03-25 |
Leiras Oy |
Emättimensisäinen antosysteemi
|
GB9326255D0
(en)
*
|
1993-12-23 |
1994-02-23 |
Roussel Lab Ltd |
Medical device for the prevention and treatment of cancer
|
ES2166894T3
(es)
|
1995-07-04 |
2002-05-01 |
Akzo Nobel Nv |
Dispositivos anulares.
|
GB9522403D0
(en)
*
|
1995-11-01 |
1996-01-03 |
Hoechst Roussel Ltd |
Intravaginal drug delivery device
|
US6030375A
(en)
*
|
1996-03-29 |
2000-02-29 |
Iotek, Inc. |
Compressible vaginal insert and method for treating urogenital disorders
|
US5816248A
(en)
*
|
1996-03-29 |
1998-10-06 |
Iotek, Inc. |
Channeled vaginal insert and method for treating urogenital disorders
|
US5988169A
(en)
*
|
1996-03-29 |
1999-11-23 |
Iotek, Inc. |
Vaginal insert and method for treating urogenital disorders
|
WO1998000184A1
(en)
|
1996-07-03 |
1998-01-08 |
Ultrafem, Inc. |
Method and system for manufacturing elastomeric articles
|
US5972372A
(en)
*
|
1996-07-31 |
1999-10-26 |
The Population Council, Inc. |
Intravaginal rings with insertable drug-containing core
|
TW358031B
(en)
*
|
1997-04-11 |
1999-05-11 |
Akze Nobel N V |
Drug delivery system for 2 or more active substances
|
US6039968A
(en)
*
|
1997-06-24 |
2000-03-21 |
Hoechst Marion Roussel |
Intravaginal drug delivery device
|
ATE313422T1
(de)
*
|
1998-05-01 |
2006-01-15 |
Duramed Pharmaceuticals Inc |
Verfahren zur spritzgussherstellung von vorrichtungen mit kontrollierter wirkstofffreisetzung und damit hergestellte vorrichtung
|
EP1313422B1
(en)
*
|
2000-08-24 |
2010-01-20 |
Sidney Lerner |
Non-hormonal vaginal contraceptive
|
AU2002211629A1
(en)
*
|
2000-10-10 |
2002-04-22 |
Microchips, Inc. |
Microchip reservoir devices using wireless transmission of power and data
|
HUP0401438A3
(en)
*
|
2001-08-31 |
2008-04-28 |
Schering Oy |
Drug delivery system
|
US7497855B2
(en)
*
|
2002-09-04 |
2009-03-03 |
Microchips, Inc. |
Method and device for the controlled delivery of parathyroid hormone
|
US7357046B2
(en)
|
2002-12-16 |
2008-04-15 |
N. V. Organon |
Method for dissolution testing of a pharmaceutical delivery device
|
WO2004096151A2
(en)
*
|
2003-04-29 |
2004-11-11 |
The General Hospital Corporation |
Methods and devices for the sustained release of multiple drugs
|
TWI336627B
(en)
|
2003-05-23 |
2011-02-01 |
Organon Nv |
Drug delivery system,and use and manufacturing method thereof
|
DE602005015090D1
(de)
|
2004-03-24 |
2009-08-06 |
Organon Nv |
Arzneimittelabgabesystem auf basis von polyethylen-vinylacetat-copolymeren
|
US20080076975A1
(en)
*
|
2005-01-25 |
2008-03-27 |
Microchips, Inc. |
Method and implantable device with reservoir array for pre-clinical in vivo testing
|
EP1843783B1
(en)
*
|
2005-01-25 |
2012-05-30 |
MicroCHIPS, Inc. |
Control of drug release by transient modification of local microenvironments
|
CN1899643B
(zh)
*
|
2005-07-20 |
2010-12-29 |
上海市计划生育科学研究所 |
含有抗雌激素和抗孕激素复合制剂的阴道环或宫内释药装置及其制药用途
|
US8399012B2
(en)
|
2006-04-17 |
2013-03-19 |
Kimberly-Clark Worldwide, Inc. |
Degradable therapeutic delivery device
|
US8741329B2
(en)
|
2007-09-21 |
2014-06-03 |
Merck Sharp & Dohme B.V. |
Drug delivery system
|
TW200927141A
(en)
*
|
2007-11-22 |
2009-07-01 |
Bayer Schering Pharma Oy |
Vaginal delivery system
|
MX337634B
(es)
|
2008-02-04 |
2016-03-14 |
Teva Womens Health Inc |
Anillos intravaginales monoliticos que comprenden progesterona y metodos de manufactura y uso de los mismos.
|
US20100040671A1
(en)
*
|
2008-08-12 |
2010-02-18 |
Ahmed Salah U |
Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
|
US8419793B2
(en)
*
|
2008-09-19 |
2013-04-16 |
Mentor Worldwide Llc |
Coating with antimicrobial agents
|
US8420153B2
(en)
*
|
2008-09-19 |
2013-04-16 |
Mentor Worldwide Llc |
Coating with antimicrobial agents
|
CN102596097B
(zh)
|
2009-06-03 |
2015-05-20 |
弗赛特实验室有限责任公司 |
一种眼插入件
|
CA2767967C
(en)
|
2009-07-21 |
2014-10-21 |
The Population Council, Inc. |
Multi-layered gradient vaginal ring
|
EA201290972A1
(ru)
|
2010-05-05 |
2013-08-30 |
Тева Вимен'С Хелс, Инк. |
Способы уменьшения симптомов у субъектов с применением лекарственных форм для однократного введения с постепенно снижающимися скоростями высвобождения
|
US8580294B2
(en)
|
2010-10-19 |
2013-11-12 |
International Partnership For Microbicides |
Platinum-catalyzed intravaginal rings
|
WO2012121811A1
(en)
|
2011-03-04 |
2012-09-13 |
Arstat, Inc. |
Treatment of excessive menstrual blood loss by intravaginal administration of low doses of antifibronlytic or hemostatic agent
|
WO2012121767A1
(en)
|
2011-03-09 |
2012-09-13 |
Arstat, Inc. |
Treatment of uterine fibroids by intravaginal administration of a low dose of selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestational agent
|
WO2012121778A1
(en)
|
2011-03-10 |
2012-09-13 |
Arstat, Inc. |
Treatment of endometriosis by intravaginal administration of selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestational agent
|
WO2012138542A1
(en)
*
|
2011-04-07 |
2012-10-11 |
Arstat, Inc. |
Treatment of menstrual pain and excessive menstrual blood loss by intravaginal administration of a low dose of antifibrinolytic or hemostatic agent in combination with non- steroidal anti-inflammatory drug
|
CN105853445A
(zh)
*
|
2011-06-06 |
2016-08-17 |
橡冠科学研究院 |
采用芯吸释放窗口的药物递送装置
|
RU2740680C2
(ru)
|
2011-09-14 |
2021-01-19 |
Форсайт Вижн5, Инк. |
Глазное вкладочное устройство и способы
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
EP2782584B1
(en)
|
2011-11-23 |
2021-06-09 |
TherapeuticsMD, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
AU2013334169B2
(en)
|
2012-10-26 |
2018-03-29 |
Forsight Vision5, Inc. |
Ophthalmic system for sustained release of drug to eye
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
WO2015055789A1
(en)
|
2013-10-17 |
2015-04-23 |
Bayer Pharma Aktiengesellschaft |
INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION
|
US10137031B2
(en)
|
2013-11-14 |
2018-11-27 |
International Partnership For Microbicides, Inc. |
Combination therapy intravaginal rings
|
US10413504B2
(en)
|
2013-12-11 |
2019-09-17 |
Merck Sharp & Dohme Corp. |
Intravaginal ring drug delivery system
|
WO2015086489A1
(en)
|
2013-12-11 |
2015-06-18 |
Merck Sharp & Dohme B.V. |
Drug delivery system for delivery of anti-virals
|
DE102014004388A1
(de)
*
|
2014-03-26 |
2015-10-01 |
Angela Kayser |
Verfahren und System zum intravaginalen Verabreichen von Progesteron
|
JP2017516768A
(ja)
|
2014-05-22 |
2017-06-22 |
セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. |
天然の併用ホルモン補充療法剤及び療法
|
US20160296532A1
(en)
|
2015-04-13 |
2016-10-13 |
Forsight Vision5, Inc. |
Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
|
CA2985717A1
(en)
|
2015-05-13 |
2016-11-17 |
Bayer Oy |
A long acting drug delivery device and its use in contraception
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
DK3432889T3
(da)
*
|
2016-03-23 |
2022-10-17 |
Univ North Carolina Chapel Hill |
Geometrisk komplekse intravaginale ringe, systemer og fremgangsmåder til fremstilling deraf
|
MX2018011705A
(es)
|
2016-04-01 |
2019-06-10 |
Therapeuticsmd Inc |
Composicion farmaceutica de hormona esteroide.
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
WO2018202574A1
(en)
|
2017-05-04 |
2018-11-08 |
Bayer Oy |
Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
|
DE102017113166A1
(de)
|
2017-06-14 |
2018-12-20 |
Amw Gmbh |
Depotform zur Abgabe eines Östrogen-Wirkstoffs
|
CA3080325A1
(en)
|
2017-10-27 |
2019-05-02 |
Renovia Inc. |
Devices, systems, and methods for training pelvic floor muscles
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|